Tower Research Capital LLC (Trc) Kymera Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,462 shares of KYMR stock, worth $99,046. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,462

Previous 13,125 81.24%

Holding current value

$99,046

Previous $391,000 70.33%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$30.16 - $52.4 $321,596 - $558,741	-10,663 Reduced 81.24%	2,462 $116,000
Q2 2024 Aug 13, 2024	BUY	$29.85 - $39.42 $370,766 - $489,635	12,421 Added 1764.35%	13,125 $391,000
Q1 2024 May 15, 2024	SELL	$22.9 - $43.57 $46,922 - $89,274	-2,049 Reduced 74.43%	704 $28,000
Q4 2023 Feb 13, 2024	SELL	$10.97 - $26.84 $42,772 - $104,649	-3,899 Reduced 58.61%	2,753 $70,000
Q3 2023 Nov 14, 2023	BUY	$13.9 - $23.88 $52,166 - $89,621	3,753 Added 129.46%	6,652 $92,000
Q2 2023 Aug 14, 2023	BUY	$22.4 - $34.92 $25,670 - $40,018	1,146 Added 65.37%	2,899 $66,000
Q1 2023 May 09, 2023	SELL	$24.84 - $38.75 $90,566 - $141,282	-3,646 Reduced 67.53%	1,753 $52,000
Q4 2022 Feb 10, 2023	SELL	$19.57 - $30.92 $258,774 - $408,855	-13,223 Reduced 71.01%	5,399 $135,000
Q3 2022 Nov 10, 2022	BUY	$20.91 - $34.27 $148,314 - $243,077	7,093 Added 61.52%	18,622 $405,000
Q2 2022 Aug 15, 2022	BUY	$14.13 - $42.55 $118,169 - $355,845	8,363 Added 264.15%	11,529 $227,000
Q1 2022 May 12, 2022	SELL	$35.3 - $64.68 $51,184 - $93,786	-1,450 Reduced 31.41%	3,166 $134,000
Q4 2021 Feb 14, 2022	BUY	$49.91 - $65.56 $45,418 - $59,659	910 Added 24.55%	4,616 $293,000
Q3 2021 Nov 15, 2021	BUY	$47.8 - $66.66 $94,930 - $132,386	1,986 Added 115.47%	3,706 $218,000
Q2 2021 Aug 16, 2021	BUY	$31.08 - $51.95 $7,334 - $12,260	236 Added 15.9%	1,720 $83,000
Q1 2021 May 17, 2021	BUY	$35.64 - $85.46 $26,159 - $62,727	734 Added 97.87%	1,484 $58,000
Q4 2020 Feb 16, 2021	SELL	$28.07 - $87.83 $6,175 - $19,322	-220 Reduced 22.68%	750 $47,000
Q3 2020 Nov 16, 2020	BUY	$26.1 - $33.28 $25,317 - $32,281	970 New	970 $31,000

Others Institutions Holding KYMR

# of Institutions

184

Shares Held

64.4M

Call Options Held

50.6K

Put Options Held

81.7K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.2B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Kymera Therapeutics, Inc. Transaction History